VYYRF News and Press, Voyageur Minerals Ltd From 08/03/23

2023-08-03 11:04:20 ET Voyageur Pharmaceuticals press release ( OTCPK:VYYRF ): Q2 GAAP EPS of -$0.51. Revenue of $4.85M (+583.1% Y/Y). Voyager had collaboration revenue of $4.9 million for the second quarter of 2023, compared to $0.7 million for the sam...

(TheNewswire) Calgary, Alberta - TheNewswire - August 1, 2023 - Voyageur Pharmaceuticals Ltd. ( TSX.V:VM ) ( USA: VYYRF ) (the " Company " or " Voyageur ") announces that it has filed its interim financial statements and management's discu...

(TheNewswire) Calgary, Alberta - TheNewswire - July 13, 2023 - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) (the " Company " or " Voyageur ") announces that on July 10, 2023, it issued 383,360 Deferred Share Units ("DSUs") to directors of the ...

(TheNewswire) Calgary, Canada – TheNewswire - June 12, 2023 - Voyageur Pharmaceuticals Ltd . ( TSXV:VM ) ( USA : VYYRF) ("Voyageur" or the "Corporation"), a provider of innovative medical imaging solutions, is pleased to announce the release of the whi...

(NewsDirect) Voyageur Pharmaceuticals CEO Brent Willis joins Natalie Stoberman from the Proactive studios to discuss the successful completion of environmental and geotechnical field work assessment at its Frances Creek project site through its 100% owned subsidiary Voyageur Industrial Mi...

(NewsDirect) Proactive research analyst John Savin speaks to Thomas Warner after publishing a new research note on Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF), a Canadian company that specialises in transforming raw materials into pharmaceutical-grade contrast agents that can be us...

(TheNewswire) Calgary, AB - TheNewswire - May 31, 2023 - Voyageur Pharmaceuticals Ltd. ( TSXV:VM ) ( OTC :VYYRF) (" Voyageur " or the " Corporation ") announces the successful completion of environmental and geotechnical fi...

--News Direct-- Voyageur Pharmaceuticals CEO Brent Willis join's Proactive's Natalie Stoberman to share a significant licensing agreement with Rain Cage Carbon to develop nanocarbon-based contrast drugs for medical imaging. Willis says the partnership aims to develop new contrast agen...

--News Direct-- Click Image To View Full Size Calgary, Canada – TheNewswire - May 24, 2023 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) ("Voyageur" or the "Corporation"), announces it has entered into a groundbreaking  development and license agreement with Rain C...

(TheNewswire) Calgary, AB - TheNewswire - April 28, 2023 - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) (the " Company " or " Voyageur ") announces that it has filed its interim financial statements and management's discussion and anal...